Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection

MLA

Chunyan Zhang, et al. “Apolipoprotein A1: A Novel Serum Biomarker for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection.” Oncotarget, vol. 7, Sept. 2016, pp. 70654–68. EBSCOhost, https://doi.org/10.18632/oncotarget.12203.

APA

Chunyan Zhang, Jian Zhou, Wei Guo, Xiao-Lu Ma, Lu Tian, Zi-Jun Gong, Yan Zhou, Jiong Wu, Xing-Hui Gao, Xin-Rong Yang, Bo Hu, Yun-Fan Sun, Shuang-Jian Qiu, & Jia Fan. (2016). Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection. Oncotarget, 7, 70654–70668. https://doi.org/10.18632/oncotarget.12203

Chicago

Chunyan Zhang, Jian Zhou, Wei Guo, Xiao-Lu Ma, Lu Tian, Zi-Jun Gong, Yan Zhou, et al. 2016. “Apolipoprotein A1: A Novel Serum Biomarker for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection.” Oncotarget 7 (September): 70654–68. doi:10.18632/oncotarget.12203.